Biotherapeutic protein production in mammalian cell systems is becoming commonplace as drug targets increase in complexity. Proper protein folding, assembly, and post-translational modifications are ...

tebu-bio offers recombinant protein production services using a robust, inexpensive and fast transient-expression system in Chinese hamster ovary (CHO) cells, for various research and development ...

“We have found that transfection efficiency, transgene copy number, the level of gene expression of the transformants, and the persistence of the expression phenotype are all crucial values.” Dr.

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance transient transfection systems, is hosting an educational webinar entitled “Large Scale, CHO Transient ...

Gene therapy using transiently expressed non-integrative plasmid vectors is the ideal solution for many public health applications. For example, no current therapy for diabetic foot ulcers directly ...

Transfection alters the genetic makeup of eukaryotic cells by introducing foreign nucleic acids, including DNA, RNA, and small noncoding RNAs such as siRNA, shRNA, and miRNA. Scientists use ...